Bristol-Myers Squibb launched its WorkingTogetherforPatients.com website on Monday as part of its Global Patient Week celebration.The new website shares stories of inspiration and connects with patients who are at the core of Bristol-Myers Squibb's mission. Read More »
A new report recently released by the National Center for Policy Analysis (NCPA) that examined generic-drug price increases found that drug wholesalers and independent drugstores profit from higher generic prices. Read More »
A Lincoln pharmacist pleaded guilty on Tuesday to health care fraud, admitting he cheated Nebraska's Medicaid program out of $14.4 million. Federal prosecutors said Scott Tran, owner of Tran Pharmacy, submitted hundreds of claims for TOBI, a tobramycin solution used in inhalers for cystic fibrosis patients, in the names of his customers' children. Read More »
After the Senate Judiciary Committee's Subcommittee on Antitrust, Competition Policy and Consumer Rights held a hearing on consolidations in the health insurance industry late last week, National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey released a statement. Read More »
CVS Health said on Wednesday that it is partnering with top startup accelerator MassChallenge in Boston and digital health venture fund Rock Health in San Francisco to spur innovation and expand areas of focus for connected health solutions. Read More »
Package of 15 medicines for chronic diseases will be sold for $1 per treatment per month Read More »
The U.S. Food and Drug Administration (FDA) and Novo Nordisk on Sept. 25 announced the approval of two products containing the long-acting human basal insulin and analog insulin degludec, to improve blood glucose control in adults with type 1 or 2 diabetes. Read More »
The U.S. Food and Drug Administration (FDA) on Tuesday allowed marketing of a new hearing aid that uses a laser diode and direct vibration of the eardrum to amplify sound. Read More »
Baxalta Inc. announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for approval of an investigational 20 percent concentration immunoglobulin subcutaneous treatment. Read More »
Generic drugs are inexpensive when there is competition, but less so when conditions on the supply side of the generic-drug market hamper competition, which is exactly what’s happening in the wholesale drug industry, Devon Herrick, senior fellow at the National Center for Policy Analysis, said. Read More »
Walgreens drugstores nationwide are now accepting new credit cards containing Europay, Mastercard and Visa (EMV) chips, touted as higher-security technology, which means things will be a little different at registers. Read More »
The malaria drug Daraprim, which sold in August for $13.50 a pill, underwent a price hike of more 5,000 percent to $750 per tablet last month. Read More »
GlaxoSmithKline Pharmaceuticals' (GSK) acquisition of Novartis Healthcare's vaccines business is complete, and GSK has sold its marketed oncology portfolio to Novartis India, while Novartis retains its influenza vaccine. Read More »
The Government Accountability Office (GAO) recently conducted a study of a pharmacy benefit pilot program the U.S. Department of Defense (DOD) offers to beneficiaries of Tricare, a health care plan for veterans and active military members. Read More »
A new global study on the advanced and specialized roles of pharmacists and the means supporting these developments was released last week during the World Congress of Pharmacy and Pharmaceutical Sciences late last week. Read More »
The National Community Pharmacists Association (NCPA) recently launched a five-part continuing-education video series examining how community pharmacies can adapt their pharmacy services to meet changing health care needs of customers. Read More »
CVS Health said on Monday that it is opening hearing centers in seven CVS/pharmacy stores in the Dallas and Cleveland markets and will offer optical services through five CVS/pharmacy stores in the Baltimore/Washington, D.C. market. Read More »
Sanofi US launched an authorized generic version of Arava Leflunomide tablets late last week through Winthrop, the company's U.S. generics division.Leflunomide blocks autoimmune antibodies to reduce inflammation and improve mobility for people who live with rheumatoid arthritis. Read More »
The U.S. Food and Drug Administration (FDA) granted accelerated approval on Friday for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda, marketed by Merck, works by targeting the cellular pathway known as PD-1/PD-L1, which are proteins found on the body’s immune cells and some cancer cells. Through blocking this pathway, Keytr Read More »
Pennsylvania’s pharmacy business is strong and continues to grow despite a nationwide economic slowdown, an American Pharmacy News analysis of state records show. Read More »
Alerts Sign-up
